PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 108 filers reported holding PASSAGE BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,263,528 | -30.1% | 4,959,769 | 0.0% | 1.74% | -68.7% |
| Q2 2023 | $4,668,631 | -1.7% | 4,959,769 | 0.0% | 5.54% | -44.1% |
| Q1 2023 | $4,749,971 | -30.6% | 4,959,769 | 0.0% | 9.90% | -30.1% |
| Q4 2022 | $6,844,481 | +10.4% | 4,959,769 | 0.0% | 14.16% | +34.0% |
| Q3 2022 | $6,200,000 | -47.0% | 4,959,769 | 0.0% | 10.57% | -41.1% |
| Q2 2022 | $11,705,000 | -23.9% | 4,959,769 | 0.0% | 17.94% | +16.9% |
| Q1 2022 | $15,375,000 | -51.2% | 4,959,769 | 0.0% | 15.35% | -8.9% |
| Q4 2021 | $31,495,000 | -36.2% | 4,959,769 | 0.0% | 16.84% | -17.6% |
| Q3 2021 | $49,399,000 | -24.8% | 4,959,769 | 0.0% | 20.45% | -6.0% |
| Q2 2021 | $65,667,000 | -24.3% | 4,959,769 | 0.0% | 21.76% | +28.8% |
| Q1 2021 | $86,697,000 | – | 4,959,769 | – | 16.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |